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Discussion

Abstract

Results

Current guidelines recommend patients
with POTS be prescribed an exercise
regimen as first line therapy. If this is not
effective, patients should then be
prescribed a recommended
pharmacotherapy. Through a literature
search, only studies involving 3 of the
several pharmacotherapies could be found.
Therefore, Propranolol, Desmopressin, and
Midodrine were only evaluated in this
review. Although more research is needed,
exercise remains the most efficacious
compared to pharmacotherapy. However, if
exercise alone is not enough, using
Propranolol or Desmopressin may reduce
symptoms in patients with POTS.

1. Arnold et al. Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study. (2013)
Ø A randomized double-blind cross over study with 16 participants to assess the effects of oral-low dose propranolol vs. placebo on
exercise capacity in patients with POTS and healthy subjects. Data suggests mechanism by which propranolol is working is to
increase the exercise capacity overall by increasing the stroke volume.
2. Coffin et al. Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome.
(2012)
Ø A randomized single-blind crossover study to determine if Desmopressin (DDAVP) could promote blood volume expansion in
patients with POTS therefore reducing upright tachycardia and improving patients’ symptoms. DDAVP significantly decreased
tachycardia and improved symptoms in POTS.
3. Fu et al. Exercise training versus propranolol in the treatment of postural orthostatic tachycardia syndrome. (2011)
Ø A double-blind trial with 19 participants comparing propranolol and placebo followed by 3 months of exercise training. Short-term
exercise training is superior to Beta blockade due to overall effect on adrenal function.
4. George et al. The international POTS registry: evaluating the efficacy of an exercise training intervention in a community
setting. (2016)
Ø To determine if the efficacy of an exercise training program on POTS patients would be effective within a community setting.
Exercise in a community setting is an effective treatment for POTS, improvement in quality of life in some patients, and seeing
remission in some patients.
5. Lai et al. Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and
beta‐blockers. (2009)
Ø A retrospective study of 121 participants to determine efficacy and impact of specific drug therapies used for patients with POTS
to assess their functionality to improve quality of life. Treatment with midodrine and beta-blockers was associated with overall
improvement, but beta-blockers were more likely to improve quality of life.
6. Ross et al. A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic
compared with hyperadrenergic postural tachycardia syndrome. (2014)
Ø A randomized placebo controlled double-blind cross-over study with 20 participants to determine if midodrine would act on
patients with neuropathic POTS and not on those with hyperadrenergic POTS. Placebo effect was seen in patients with
hyperadrenergic POTS, improvement only seen in patients with neuropathic POTS, but HR changes were NS.
7. Shibata et al. Short-term exercise training improves the cardiovascular response to exercise in the postural orthostatic
tachycardia syndrome. (2012)
Ø A study with 19 participants to determine if physical deconditioning, or cardiac atrophy, along with reduced blood volume,
contributed to the pathogenesis of POTS. And if short term exercise training programs would help to improve cardiovascular
response to exercise in the patients. Short term exercise (3 months) improved cardiovascular response in patients with POTS.

Introduction
Postural Orthostatic Tachycardia Syndrome
(POTS) is a condition of chronic orthostatic
intolerance which is associated with
lightheadedness, palpitations,
tremulousness, generalized weakness,
blurred vision, exercise intolerance, and
fatigue upon standing. This paper will
address the efficacy of several
recommended pharmacotherapy options,
compared to the first line treatment of
exercise, to understand how to improve
symptoms and quality of life in female
patients of childbearing age with POTS.
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results
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CO

Limited sample populations, lack of longterm data, and lack of selection from a
broader pool of patients limit all findings
from a higher statistical power of evidence.
The findings support current guidelines to
implement exercise as a first line therapy in
patients with POTS. Furthermore, they
provide additional insight into which
medications, in this case Propranolol, and
Desmopressin, have evidence to support their
efficacy at reducing symptoms in POTS. No
negative health outcomes were recorded as a
result of any of these studies and this topic of
study should be encouraged to continue to
look at long term data with larger sample
populations.

Conclusion
The evidence gathered in this investigation
supports the current guidelines. However, it is
important to consider that through this
investigation only two of the
pharmacotherapy options provided statistical
evidence of being effective in patients with
POTS. These medications were Propranolol,
a beta blocker, and Desmopressin, a
vasopressor.
These result should encourage providers to
familiarize themselves with specific exercise
programs designed to target the
cardiovascular deconditioning associated
with POTS.
Further studies should aim to include larger
sample sizes and longer duration of studies to
assess long term impact of exercise and
pharmacotherapy on patients with POTS.

